BPIQ Blog

May 17, 20212 min read

Free Biopharma Daily Stock Updates - 05/17/21

$XBI $127 -1% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days...

May 17, 20212 min read

CVM Ph3 Trial Uncertainty

CVM's pending Phase 3 report out of its long term head & neck cancer study of its immuno-oncology reagent multikne (see image for...

May 14, 20211 min read

Free Biopharma Daily Stock Updates - 05/14/21

$XBI $127 +4% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days...

May 13, 20211 min read

Free Biopharma Daily Stock Updates - 05/13/21

$XBI $123 -1% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days...

May 13, 20211 min read

HRTX Is Down on FDA Approval?

The short answer is the HTX-011 (ZYNRELEF) label language that was approved by the FDA. As we discussed in our prior posts on BPIQ.com,...

May 12, 20211 min read

Free Biopharma Daily Stock Updates - 05/12/21

XBI 124 -1% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days free,...

May 12, 20212 min read

Free Biopharma Daily Stock Updates - 05/11/21

Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days free, no credit...

May 12, 20212 min read

Free Biopharma Daily Stock Updates - 05/10/21

Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days free, no credit...

May 11, 20211 min read

HTX-011: Will 3rd PDUFA be a Charm?

HRTX has a Big-Mover PDUFA goal date tomorrow, 5/12/21. We have written quite a bit about HRTX over the past years (e.g. see our...

May 9, 20213 min read

AMRN Delaware Litigation Schedule

Last week, we received the official court scheduling order in the AMRN vs. Hikma and Health Net patent litigation in the District of...

May 8, 20211 min read

Free Biopharma Daily Stock Updates - 05/07/21

XBI $128 +2% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days...

May 6, 20211 min read

Free Biopharma Daily Stock Updates - 05/06/21

$XBI $126 -2% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days...

May 5, 20211 min read

Free Biopharma Daily Stock Updates - 05/05/21

$XBI $128 -1% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days...

May 4, 20211 min read

Free Biopharma Daily Stock Updates - 05/04/21

$XBI $129.81 -4% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days...

May 3, 20212 min read

Free Biopharma Daily Stock Updates - 05/03/21

$XBI $135 -2% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days...

May 3, 20212 min read

Will Today's KOL Event Move VXRT Higher?

VXRT shares are now up almost 100% since its 5/26/21 announcement that it was providing a knowledge leader (KOL) event on 5/3/21 at noon...

Apr 30, 20212 min read

Big-Mover Catalyst FAQs

What is a Big-Mover™ event? Big-Mover™ events are upcoming high-impact biopharma catalyst events, usually clinical trial read-outs, that...

Apr 30, 20211 min read

April Big Mover Events Moved Despite FDA Delays

Based on our April 2021 data (See Table below), the Big Mover™ analysis again appears to identify companies that are likely to move over...

Apr 30, 20211 min read

Free Biopharma Daily Stock Updates - 04/30/21

$XBI $137 -1% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days...

Apr 29, 20212 min read

Free Biopharma Daily Stock Updates - 04/29/21

$XBI $138.06 -1.17% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30...

Jump start your biotech due diligence

Get started →

Our platform helps you uncover your next biotech investment opportunity